2025 Regular Session • Idaho Legislature
H0137: Amends existing law to classify mifepristone and misoprostol as schedule IV drugs.
Legislative Summary
UNIFORM CONTROLLED SUBSTANCES -- Amends existing law to classify mifepristone and misoprostol as schedule IV drugs.
Demographic Impact
Overall analysis of equity impact
80% Bias
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/4/2025
Introduced, read first time, referred to JRA for Printing
House of Representatives
2/5/2025
Reported Printed and Referred to Health & Welfare
House of Representatives
Status Information
Current Status
Introduced(2/4/2025)
Chamber
House of Representatives
Committee
Health and Welfare(House of Representatives)